| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 11/23/2005 | EP1596656A2 Pyrazoles and methods of making and using the same |
| 11/23/2005 | EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 11/23/2005 | CN1701072A Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 11/23/2005 | CN1701069A 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
| 11/23/2005 | CN1699363A Vla-4 inhibitors |
| 11/23/2005 | CN1699350A Processes and intermediates for preparing anti-cancer compounds |
| 11/23/2005 | CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 11/22/2005 | US6967216 Neuropeptide Y receptor modulators; treating eating disorders |
| 11/22/2005 | US6967214 Inhibitors of IMPDH enzyme |
| 11/22/2005 | US6967212 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 11/22/2005 | US6967208 Anticoagulants; cardiovascular disorders |
| 11/17/2005 | WO2005108391A1 Amides as bace inhibitors |
| 11/17/2005 | WO2005108389A1 Indole derivatives having piperidine rings |
| 11/17/2005 | WO2005108384A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 11/17/2005 | WO2005108382A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 11/17/2005 | WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs |
| 11/17/2005 | WO2005108370A1 Benzene compounds |
| 11/17/2005 | WO2005108359A1 Novel compounds of proline and morpholine derivatives |
| 11/17/2005 | WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors |
| 11/17/2005 | WO2005107758A1 4-phenylamino-quinazolin-6-yl-amides |
| 11/17/2005 | WO2005058834A3 Quinolines useful in treating cardiovascular disease |
| 11/17/2005 | WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 11/17/2005 | WO2005034857A8 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 11/17/2005 | WO2004082602A3 Carboxamide spirohydantoin cgrp receptor antagonists |
| 11/17/2005 | US20050256310 Therapeutic compounds |
| 11/17/2005 | US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 11/17/2005 | US20050256185 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 11/17/2005 | US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 11/17/2005 | US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 11/17/2005 | US20050256167 Preparation and use of imidazole derivatives for treatment of obesity |
| 11/17/2005 | US20050256166 Nitrogen-containing compounds |
| 11/17/2005 | US20050256159 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors |
| 11/17/2005 | US20050256158 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 11/17/2005 | US20050256145 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/17/2005 | US20050256136 1-[2-(3-Ethyl-ureido)-3H-benzoimidazol-5-yl]-1H-imiazole-4-carboxylic acid methyl ester; bacteriostatic antibiotic; decrease antibiotic resistance of bacterial organisms; new class of compounds for bacterial infections |
| 11/17/2005 | US20050256130 Substituted piperazines |
| 11/17/2005 | US20050256123 Heterocyclic inhibitors of MEK and methods of use thereof |
| 11/17/2005 | US20050256121 Substituted 2,5-heterocyclic derivatives |
| 11/17/2005 | US20050256120 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 11/17/2005 | US20050256118 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 11/17/2005 | US20050256117 Ophthalmic compositions for treating ocular hypertension |
| 11/17/2005 | US20050256113 Anti-cytokine heterocyclic compounds |
| 11/17/2005 | US20050256110 Cyanopyrroles |
| 11/17/2005 | US20050256107 New substituted thiophene carboxamides, process for their preparation and their use as medicaments |
| 11/17/2005 | US20050256104 Protease inhibitors |
| 11/17/2005 | US20050256103 Indole derivative having piperidine ring |
| 11/17/2005 | US20050256100 Protease inhibitors |
| 11/17/2005 | US20050256099 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 11/17/2005 | US20050256098 CGRP receptor antagonists |
| 11/17/2005 | US20050256078 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups |
| 11/17/2005 | US20050256003 Novel herbicides |
| 11/17/2005 | US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use |
| 11/17/2005 | DE102004018953A1 4-Halogenalkylpyridin-3-sulfonsäureamide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-haloalkylpyridine-3-sulfonamides, process for their preparation, compositions containing them and their use as pesticides |
| 11/17/2005 | CA2565843A1 Novel compounds of proline and morpholine derivatives |
| 11/17/2005 | CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs |
| 11/17/2005 | CA2564264A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 11/16/2005 | EP1594867A2 Phenylacetamides and their use as glucokinase modulators |
| 11/16/2005 | EP1594865A2 Antibacterial agents |
| 11/16/2005 | EP1594863A1 Tri(cyclo) substituted amide glucokinase activator compounds |
| 11/16/2005 | EP1594853A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof |
| 11/16/2005 | EP1594852A1 Oxazolidinone derivatives as antimicrobials |
| 11/16/2005 | EP1594847A2 Substituted azole derivatives as therapeutic agents |
| 11/16/2005 | EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 11/16/2005 | EP1594840A1 Piperidine-benzenesulfonamide derivatives |
| 11/16/2005 | EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 11/16/2005 | EP1594495A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
| 11/16/2005 | EP1594494A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents |
| 11/16/2005 | EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 11/16/2005 | EP1370557B1 Benzimidazole anti-inflammatory compounds |
| 11/16/2005 | EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 11/16/2005 | EP1326850B1 A process for the preparation of bis-benzazolyl compounds |
| 11/16/2005 | EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 11/16/2005 | EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 11/16/2005 | EP1218374B1 Pharmaceutically active sulfonamide derivatives |
| 11/16/2005 | EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| 11/16/2005 | CN1697835A Pyridyl substituted heterocycles useful for treating or preventing HCV infection |
| 11/16/2005 | CN1696129A Novel process for the synthesis of carboxylic acid phenylamide |
| 11/16/2005 | CN1227244C Herbicidal benzoyl derivatives |
| 11/16/2005 | CN1227238C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials |
| 11/16/2005 | CN1227236C Substituted imidazole neuropeptide YY5 receptor antagonists |
| 11/16/2005 | CN1227231C Ether and amide compounds as medicine for treating glycuresis and preparing process thereof |
| 11/16/2005 | CN1227229C Ethylene derivatives and pest controlling agents containing same |
| 11/15/2005 | US6965036 Intermediates for guanidine mimics as factor Xa inhibitors |
| 11/15/2005 | US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents |
| 11/15/2005 | US6965032 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates and their preparation and use |
| 11/15/2005 | US6964983 Compounds that modulate PPAR activity and methods for their preparation |
| 11/15/2005 | US6964975 Isoxazole and thiazole compounds and use thereof as medicine |
| 11/15/2005 | US6964973 Nonsteroidal agonists and antagonists |
| 11/15/2005 | US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use |
| 11/15/2005 | US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections |
| 11/15/2005 | CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them |
| 11/15/2005 | CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 11/15/2005 | CA2179640C Watersoluble azole antifungals |
| 11/15/2005 | CA2167183C Process for making hiv protease inhibitors |
| 11/10/2005 | WO2005105817A2 Coupling process for generating reactive boron containing derivatives of n-substituted pyrrole-2 carbonitriles to produce biaryls |
| 11/10/2005 | WO2005105792A1 Process for preparing optically pure zolmitriptan |
| 11/10/2005 | WO2005105791A1 Indolyl derivatives as liver-x-receptor modulators |
| 11/10/2005 | WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases |
| 11/10/2005 | WO2005105788A1 Indole derivatives and use thereof as kinase inhibitors |
| 11/10/2005 | WO2005105780A2 Compositions useful as inhibitors of rock and other protein kinases |